Details of the Drug Formulaction

General Information of Drug Formulation (ID: F19030)

• Formulation Name: Risedronic acid 5 mg tablet
• Company: Warner Chilcott Pharmaceuticals

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Risedronate	(DM5FLTY)	Bone Paget disease		Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Crospovidone	(E00626)	Not Available	Disintegrant
Ferric hydroxide oxide yellow	(E00539)	23320441	Colorant
Hypromellose	(E00634)	Not Available	Coating agent
Lactose monohydrate	(E00393)	104938	Binding agent; Diluent; Dry powder inhaler carrier; Lyophilization aid
Magnesium stearate	(E00208)	11177	lubricant
Silicon dioxide	(E00670)	Not Available	Anticaking agent; Opacifying agent; Viscosity-controlling agent
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent